Literature DB >> 26216470

Clindamycin-induced hypersensitivity reaction.

Marilyn N Bulloch1,2,3, Jonathan T Baccas4,5, Scott Arnold4,5.   

Abstract

Drug-induced anaphylaxis is an unpredictable adverse reaction. Although it may occur with any medication, antibiotics induce more cases of anaphylaxis than any other medication class with most cases being induced by β-lactam antibiotics. Clindamycin is an antibiotic with good gram-positive and anaerobe coverage which is often used in patients with β-lactam allergies. We report the case of a 46-year-old female who experienced anaphylaxis after a dose of intravenous (IV) clindamycin. Following treatment with methylprednisolone, epinephrine, diphenhydramine, and albuterol, the patient stabilized. The patient's score on the Naranjo's algorithm was 8 (probable); a score of 9 (definite) limited only by absence of drug re-challenge. To our knowledge, this is the first report of a clindamycin-induced anaphylaxis where the patient was not exposed to any other agent that may have triggered the response, the first case in the United States, and only the third documented case in the literature. Clinicians should be aware of the potential for drug-induced anaphylaxis in all medications.

Entities:  

Keywords:  Allergic reaction; Anaphylaxis; Clindamycin; Hypersensitivity

Mesh:

Substances:

Year:  2015        PMID: 26216470     DOI: 10.1007/s15010-015-0826-2

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Drug allergy: an updated practice parameter.

Authors: 
Journal:  Ann Allergy Asthma Immunol       Date:  2010-10       Impact factor: 6.347

2.  Clindamycin-induced anaphylactic shock during general anesthesia.

Authors:  Chiuan-Shiou Chiou; Su-Man Lin; Shih-Pin Lin; Wen-Guei Chang; Kwok-Hon Chan; Chien-Kun Ting
Journal:  J Chin Med Assoc       Date:  2006-11       Impact factor: 2.743

3.  Anaphylactic shock following the administration of clindamycin.

Authors:  O Lochmann; P Kohout; F Výmola
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1977

4.  Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department.

Authors:  M Moro Moro; M A Tejedor Alonso; J Esteban Hernández; M V Múgica García; A Rosado Ingelmo; C Vila Albelda
Journal:  J Investig Allergol Clin Immunol       Date:  2011       Impact factor: 4.333

5.  The diagnosis and management of anaphylaxis practice parameter: 2010 update.

Authors:  Phillip Lieberman; Richard A Nicklas; John Oppenheimer; Stephen F Kemp; David M Lang; David I Bernstein; Jonathan A Bernstein; A Wesley Burks; Anna M Feldweg; Jordan N Fink; Paul A Greenberger; David B K Golden; John M James; Stephen F Kemp; Dennis K Ledford; Phillip Lieberman; Albert L Sheffer; David I Bernstein; Joann Blessing-Moore; Linda Cox; David A Khan; David Lang; Richard A Nicklas; John Oppenheimer; Jay M Portnoy; Christopher Randolph; Diane E Schuller; Sheldon L Spector; Stephen Tilles; Dana Wallace
Journal:  J Allergy Clin Immunol       Date:  2010-08-07       Impact factor: 10.793

  5 in total
  4 in total

1.  Photodynamic Therapy as an adjunct in the Treatment of Medication-Related Osteonecrosis of the Jaw: A Case Report.

Authors:  Marcelo Vieira da Costa Almeida; Antonio C Moura; Lúcia Santos; Luciana Gominho; Ully Dias Nascimento Távora Cavalcanti; Kaline Romeiro
Journal:  J Lasers Med Sci       Date:  2021-03-08

2.  A Survey of Systemic Antibiotic Prescription Patterns Amongst Iraqi Dentists.

Authors:  Zaid A Al Marah; Ali A Abdulkareem; Sarhang S Gul; Muhanad L Alshami
Journal:  Int Dent J       Date:  2021-07-31       Impact factor: 2.607

Review 3.  Antimicrobial Desensitization: A Review of Published Protocols.

Authors:  Daniel B Chastain; Vanessa Johanna Hutzley; Jay Parekh; Jason Val G Alegro
Journal:  Pharmacy (Basel)       Date:  2019-08-09

Review 4.  Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole.

Authors:  Michelle Dilley; Bob Geng
Journal:  Clin Rev Allergy Immunol       Date:  2021-12-15       Impact factor: 10.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.